Plunkett Research Online: Synthetic Biologics Inc

SYNTHETIC BIOLOGICS INC (SYN) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbio.....


SYNTHETIC BIOLOGICS INC

Ticker: SYN
Exchange: ASE
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 734 332-7800
Fax:
Address: 3985 Research Park Drive
Ann Arbor, MI 48108 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Steven ShallcrossCEO/CFO/Chief Accounting Officer/Director
Jeffrey KrawsChairman of the Board/Director
See More
Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbio.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture